1. Home
  2. Medical News
  3. OB/GYN and Women's Health
advertisement

Postpartum Depressive Symptoms Linked to Slightly Lower Bonding Scores

Simplified mother and infant silhouettes representing self reported bonding during the early postpartum period
11/20/2026

Key Takeaways

  • Among mothers assessed at 4-24 weeks postpartum, higher depressive symptom severity was associated with slightly lower self-reported mother–infant bonding after adjustment.
  • The highest bonding score occurred in 39.2% of participants, Tobit and fractional-logit models yielded similar observed-scale estimates.
  • Stressful breastfeeding and nonbreastfeeding were associated with higher depressive symptom scores in exploratory adjusted analyses, not tests of an intervention.
In a study published in the Journal of Clinical Medicine, investigators assessed 212 mothers at 4–24 weeks postpartum during April–June 2025. In this cross-sectional assessment, the Edinburgh Postnatal Depression Scale (EPDS) measured depressive symptoms, and the Maternal Attachment Inventory (MAI) measured self-reported bonding. An EPDS score of 13 or higher defined a positive screen for probable postpartum depression. Adjusted linear regression used heteroskedasticity-consistent type 3 (HC3) robust standard errors and accounted for infant age and selected clinical and psychosocial covariates. Clustering at the highest MAI score prompted complementary Tobit, fractional-logit, and ordinal sensitivity models, alongside exploratory spline assessments.

After adjustment, each additional EPDS point corresponded to 0.20 fewer MAI points (95% confidence interval −0.26 to −0.15); five additional EPDS points corresponded to approximately one fewer MAI point. This is a difference on the observed bonding scale, not a measured change in an individual mother's bonding over time. Observed-scale estimates were similar in the linear, Tobit, and fractional-logit models.

41 mothers (19.3%) screened positive for probable postpartum depression. In exploratory adjusted analyses, stressful breastfeeding and nonbreastfeeding were associated with higher EPDS scores; these were associations with symptom scores, not bonding outcomes or intervention effects. Separately, four of 69 unadjusted exploratory comparisons survived false-discovery-rate correction. All involved positive screening status and breastfeeding or spousal support, rather than the adjusted analysis of continuous symptom scores.

The authors described the absolute bonding-score difference as small and its clinical significance as uncertain. Because symptoms and perceived bonding were measured concurrently, the association cannot establish whether depressive symptoms caused lower perceived bonding. The concentration of MAI scores at the maximum motivated complementary models but did not change the cross-sectional design. The exploratory breastfeeding and support findings also describe observed associations, not the effects of changing those circumstances.

Greater depressive symptom severity accompanied slightly lower self-reported mother–infant bonding in this cross-sectional postpartum sample, but the clinical significance remains uncertain and the association does not establish causation.

Clinician Questions

Was the association between EPDS symptoms and mother–infant bonding linear at the extremes of postpartum symptom scores?

Exploratory spline analyses suggested that the relationship between Edinburgh Postnatal Depression Scale symptom severity and Maternal Attachment Inventory bonding scores might depart from linearity at the lowest or highest symptom scores. Observations at those extremes were sparse, and spline results varied with model specification, so the pattern was not conclusive.

Does an EPDS score of 13 or higher confirm postpartum depression in mothers at 4–24 weeks postpartum?

An Edinburgh Postnatal Depression Scale score at or above 13 indicated a positive screen for probable postpartum depression, not a clinically confirmed diagnosis.

This content is intended for healthcare professionals for educational purposes. The article and its image were developed with AI assistance and reviewed by members of the ReachMD team prior to publication. Please refer to the original source linked for the complete and most up-to-date information.

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free